AMBIEN (zolpidem tartrate) by Almatica Pharma is short-term treatment of insomnia through binding to the benzodiazepine site of α1 subunit containing gaba a receptors, increasing the frequency of chloride channel opening resulting in the inhibition of neuronal excitation. Approved for insomnia. First approved in 1992.
Drug data last refreshed 19h ago · AI intelligence enriched 3w ago
Ambien (zolpidem tartrate) is an oral tablet medication approved in 1992 for the short-term treatment of insomnia. It works by binding to the benzodiazepine site of α1 subunit-containing GABA A receptors, increasing chloride channel opening frequency and inhibiting neuronal excitation to promote sleep. As a non-benzodiazepine hypnotic (Z-drug), it represents a standard first-line pharmacologic option for insomnia management.
short-term treatment of insomnia through binding to the benzodiazepine site of α1 subunit containing GABA A receptors, increasing the frequency of chloride channel opening resulting in the inhibition of neuronal excitation.
A Randomized Controlled Trial of Ambient Artificial Intelligence Scribe Technologies
Health Effects of Repeated Exposure to Low Levels of Concentrated Ambient Particles in Healthy Young Volunteers
Astigmatism Correction With Intrastromal Arcuate Incisions in Eyes Undergoing Cataract Surgery With Femtosecond Laser Using the Cassini Ambient With Iris Registration (ARCUATAS)
Fexinidazole in Human African Trypanosomiasis Due to T.b. Gambiense at Any Stage
Effects of Omega-3 Fatty Acids in Ambient Air Pollution Exposure in Healthy Adults
Worked on AMBIEN at Almatica Pharma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moWith zero linked job openings currently, career activity on Ambien is minimal as the franchise approaches LOE. Roles that do exist are typically limited to portfolio management, legal/regulatory affairs for generic defense strategies, and customer service functions. Skills relevant to this stage include pricing analytics, managed care negotiation, and lifecycle extension strategy; however, limited innovation opportunity means most talent in this space is focused on organizational efficiency rather than growth initiatives.